OBJECTIVES: We compared the likelihood that a tobacco user would receive treatment with the likelihood that an adult with another common chronic condition would receive treatment for that condition at an office visit. METHODS: We analyzed data from the 2005-2007 National Ambulatory Medical Care Survey to compare the proportion of US office visits at which tobacco users and individuals with hypertension, hyperlipidemia, diabetes, asthma, or depression received condition-specific treatment. We calculated the odds that a visit for a comparison condition would result in treatment relative to a visit for tobacco dependence. RESULTS: From 2005 to 2007, 38, 004 patient visits involved at least 1 study condition. Tobacco users received medication at fewer visits (4.4%) than individuals with hypertension (57.4%), diabetes (46.2%), hyperlipidemia (47.1%), asthma (42.6%), and depression (53.3%). In multivariate analyses, the odds for pharmacological treatment of these disorders relative to tobacco use were, for hypertension, 32.8; diabetes, 20.9; hyperlipidemia, 16.5; asthma, 22.1; and depression, 24.0 (all Ps < .001). Patients with hypertension, diabetes, or hyperlipidemia were also more likely to receive behavioral counseling. CONCLUSIONS: Alternate models of engagement may be needed to enhance use of effective treatments for tobacco use.
OBJECTIVES: We compared the likelihood that a tobacco user would receive treatment with the likelihood that an adult with another common chronic condition would receive treatment for that condition at an office visit. METHODS: We analyzed data from the 2005-2007 National Ambulatory Medical Care Survey to compare the proportion of US office visits at which tobacco users and individuals with hypertension, hyperlipidemia, diabetes, asthma, or depression received condition-specific treatment. We calculated the odds that a visit for a comparison condition would result in treatment relative to a visit for tobacco dependence. RESULTS: From 2005 to 2007, 38, 004 patient visits involved at least 1 study condition. Tobacco users received medication at fewer visits (4.4%) than individuals with hypertension (57.4%), diabetes (46.2%), hyperlipidemia (47.1%), asthma (42.6%), and depression (53.3%). In multivariate analyses, the odds for pharmacological treatment of these disorders relative to tobacco use were, for hypertension, 32.8; diabetes, 20.9; hyperlipidemia, 16.5; asthma, 22.1; and depression, 24.0 (all Ps < .001). Patients with hypertension, diabetes, or hyperlipidemia were also more likely to receive behavioral counseling. CONCLUSIONS: Alternate models of engagement may be needed to enhance use of effective treatments for tobacco use.
Authors: Michael B Steinberg; Ayse Akincigil; Cristine D Delnevo; Stephen Crystal; Jeffrey L Carson Journal: Am J Prev Med Date: 2006-03-23 Impact factor: 5.043
Authors: Michael V Maciosek; Ashley B Coffield; Nichol M Edwards; Thomas J Flottemesch; Michael J Goodman; Leif I Solberg Journal: Am J Prev Med Date: 2006-07 Impact factor: 5.043
Authors: Molly B Conroy; Nicola E Majchrzak; Susan Regan; Caroline B Silverman; Louise I Schneider; Nancy A Rigotti Journal: Nicotine Tob Res Date: 2005-04 Impact factor: 4.244
Authors: Carol Bennett; Sara Khangura; Jamie C Brehaut; Ian D Graham; David Moher; Beth K Potter; Jeremy M Grimshaw Journal: PLoS Med Date: 2011-08-02 Impact factor: 11.069
Authors: Steven L Bernstein; Gail D'Onofrio; June Rosner; Stephanie O'Malley; Robert Makuch; Susan Busch; Michael V Pantalon; Benjamin Toll Journal: Ann Emerg Med Date: 2015-04-24 Impact factor: 5.721
Authors: Alana M Rojewski; Steffani R Bailey; Steven L Bernstein; Nina A Cooperman; Ellen R Gritz; Maher A Karam-Hage; Megan E Piper; Nancy A Rigotti; Graham W Warren Journal: Nicotine Tob Res Date: 2019-10-26 Impact factor: 4.244
Authors: Krysten W Bold; Yanhong Deng; James Dziura; Elizabeth Porter; Keith M Sigel; Jessica E Yager; David M Ledgerwood; Steven L Bernstein; E Jennifer Edelman Journal: Transl Behav Med Date: 2022-07-07 Impact factor: 3.626
Authors: Titus J Brinker; Sabine Stamm-Balderjahn; Werner Seeger; Doris Klingelhöfer; David A Groneberg Journal: BMJ Open Date: 2015-09-18 Impact factor: 2.692
Authors: Kimber P Richter; Theresa I Shireman; Edward F Ellerbeck; A Paula Cupertino; Delwyn Catley; Lisa Sanderson Cox; Kristopher J Preacher; Ryan Spaulding; Laura M Mussulman; Niaman Nazir; Jamie J Hunt; Leah Lambart Journal: J Med Internet Res Date: 2015-05-08 Impact factor: 5.428
Authors: Dennis Thomas; Andrew J Mackinnon; Billie Bonevski; Michael J Abramson; Simone Taylor; Susan G Poole; Gregory R Weeks; Michael J Dooley; Johnson George Journal: BMJ Open Date: 2016-03-31 Impact factor: 2.692